Pathobiotek Diagnostics, Inc.

Pathobiotek Diagnostics Inc., (PDI) is a research and development company engaged in the discovery, identification, and characterization of novel microbial agents. Among the microbial agents that scientists at PDI have identified is an organism that may be associated with symptoms in multiple sclerosis (MS) patients. This organism has not been previously characterized or associated with any specific human disease. PDI has conducted studies that have shown a 100% correlation between clinical improvement and reduction of levels of organism in MS patients. A similar correlation with this organism has been seen in the treatment of other disorders, such as Chronic Fatigue Syndrome (CFS) and certain autoimmune diseases.

Activity:

- Other Industry Services

Product / Technology type(s) covered:

- Bio
- Diagnostics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: